535 Pill - pink capsule/oblong, 16mm

Pill with imprint 535 is Pink, Capsule/Oblong and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.

Minocycline is used in the treatment of Acne; Bacterial Infection; Bartonellosis; Actinomycosis; Bullous Pemphigoid and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 535

Minocycline Hydrochloride Extended-Release

Imprint: 535
Strength: 135 mg
Color: Pink
Size: 16.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Tetracyclines
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: Zydus Pharmaceuticals (USA) Inc.
Manufacturer: Cadila Healthcare Limited
National Drug Code (NDC): 70771-1167
Inactive Ingredients: D&C Red No. 27, D&C Yellow No. 10, FD&C Blue No. 2, hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol 3350, silicon dioxide, titanium dioxide, triacetin
Note: Inactive ingredients may vary.